¼¼°èÀÇ ¸®µå¸®½º ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀå º¸°í¼­(2025³â)
Leadless Pacemakers Global Market Report 2025
»óǰÄÚµå : 1705255
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,339,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,163,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,987,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¸®µå¸®½º ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È ¿¬Æò±Õ 15.4%ÀÇ ¼ºÀå·ü(CAGR)·Î 2029³â±îÁö 12¾ï ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº ÀÓ»ó ÀûÀÀÁõ È®´ë, Àα¸ °í·ÉÈ­, ȯÀÚ ¾ÈÀü°ú °á°ú¿¡ ´ëÇÑ °ü½É Áõ°¡, Áö¼Ó°¡´É¼º¿¡ ´ëÇÑ °ü½É Áõ°¡, ÀÏ¹Ý ´ëÁßÀÇ Àνİú ±³À° Áõ°¡¿¡ ±âÀÎÇÏ´Â °ÍÀ¸·Î ºÐ¼®µË´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ±â¼ú ¹ßÀü°ú Çõ½Å, ¿þ¾î·¯ºí ¹× µðÁöÅÐ Çコ ±â¼ú°úÀÇ ÅëÇÕ, ¹èÅ͸® ¼ö¸í ¿¬Àå ¹× ³»±¸¼º, ȯÀÚ Á᫐ ¼³°è ¹× ¸ÂÃãÈ­, Çù¾÷ ¹× ÆÄÆ®³Ê½Ê µîÀ» ²ÅÀ» ¼ö ÀÖ½À´Ï´Ù.

ÇâÈÄ ½ÉÀå ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ ¸®µå¸®½º ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀåÀÇ ¼ºÀåÀÌ ÃËÁøµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÉÀå ÁúȯÀº ½ÉÀåÀÇ ±¸Á¶¿Í ±â´É¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ´Ù¾çÇÑ »óŸ¦ Æ÷ÇÔÇϸç, Ç÷·ù Àå¾Ö, ½ÉÀå ¸®µë ÀÌ»ó, ±âŸ ½ÉÇ÷°ü°è ÇÕº´Áõ°ú °°Àº ¹®Á¦¸¦ À¯¹ßÇÕ´Ï´Ù. ½ÉÀå ÁúȯÀÇ Áõ°¡´Â Àα¸ Áõ°¡¿Í °í·ÉÈ­, »ýȰ½À°ü ¼±ÅÃ, ½ºÆ®·¹½º, ¿îµ¿ ºÎÁ·, ÀÇ·á ½Ã½ºÅÛ ³» ¹®Á¦, À¯ÀüÀû ¹× ȯ°æÀû ¿äÀÎ µîÀÇ ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. ¸®µå¸®½º ÆäÀ̽º¸ÞÀÌÄ¿´Â È¿°úÀûÀÎ ÆäÀ̽ÌÀ» Á¦°øÇÏ´Â µ¿½Ã¿¡ ±âÁ¸ ½É¹Úµ¿±âÀÇ ÇÕº´Áõ À§ÇèÀ» ÁÙÀÌ°í ´ú ħ½ÀÀûÀÎ ÀÌ½Ä ½Ã¼úÀ» Á¦°øÇÔÀ¸·Î½á ƯÁ¤ ½ÉÀå ÁúȯÀ» °ü¸®ÇÏ´Â µ¥ Å« ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 2¿ù ¼¼°èº¸°Ç±â±¸(WHO)´Â 2050³â±îÁö 3,500¸¸ ¸í ÀÌ»óÀÇ ½ÉÀ庴 ȯÀÚ°¡ »õ·Î ¹ß»ýÇÒ °ÍÀ¸·Î ¿¹ÃøÇßÀ¸¸ç, ÀÌ´Â 2022³â ÃßÁ¤Ä¡ÀÎ 2,000¸¸ ¸íº¸´Ù 77% Áõ°¡ÇÑ ¼öÄ¡ÀÔ´Ï´Ù. ÀÌó·³ ½ÉÀ庴 À¯º´·üÀÇ Áõ°¡´Â ¸®µå¸®½º ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¸®µå¸®½º ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéÀº º¸´Ù ´Ù¾çÇÑ ½ÉÀå Áúȯ¿¡ ´ëÀÀÇϰí ȯÀڵ鿡°Ô º¸´Ù ¸ÂÃãÈ­µÈ Ä¡·á ¿É¼ÇÀ» Á¦°øÇϱâ À§ÇØ µà¾ó è¹ö ¸®µå¸®½º ÆäÀ̽º¸ÞÀÌÄ¿¿Í °°Àº Çõ½ÅÀûÀÎ Á¦Ç° °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. µà¾ó è¹öÇü ¸®µå¸®½º ÆäÀ̽º¸ÞÀÌÄ¿´Â ±âÁ¸ÀÇ ÆäÀÌ½Ì ¸®µå¸¦ »ç¿ëÇÏÁö ¾Ê°í ¿ì½É¹æ°ú ½É½Ç¿¡ Àü±â ÀÚ±ØÀ» °ø±ÞÇÏ¿© ½ÉÀå ¸®µëÀ» Á¶ÀýÇϵµ·Ï ¼³°èµÈ ½ÉÀå ÆäÀÌ½Ì ÀåÄ¡ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 2¿ù ¹Ì±¹ ÀÇ·á±â±â ¹× ÇコÄÉ¾î ±â¾÷ ¾Öº¸Æ® ·¡¹ö·¯Å丮½º(Abbott Laboratories)´Â ¿ì½É¹æ°ú ½É½Ç¿¡ µ¿±âÈ­µÈ ½É¹Ú¼ö¸¦ Á¦°øÇÏ´Â µà¾ó è¹öÇü ½É¹ÚÁ¶À²±âÀÎ ¿¡À̺긱 DR(Abeil DR)À» Ãâ½ÃÇß½À´Ï´Ù. ¿¡À̺긱 DR ½Ã½ºÅÛÀº µ¶ÀÚÀûÀÎ i2iTM Åë½Å ±â¼úÀ» Ȱ¿ëÇÏ¿© ½É¹æ°ú ½É½Ç °£ ¹Úµ¿ µ¿±âÈ­ ÆäÀ̽ÌÀ» °¡´ÉÇÏ°Ô Çϸç, Áö¼ÓÀûÀÎ ¹æ½Ç µ¿±âÈ­¸¦ À§ÇÑ ÁøÁ¤ÇÑ µà¾ó è¹ö ¼Óµµ Á¶Àý(DDDR) ÆäÀ̽ÌÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ Çõ½ÅÀûÀÎ ¸®µå¸®½º ÆäÀ̽º¸ÞÀÌÄ¿ ½Ã½ºÅÛÀº ¾ç½É½Ç ¹Úµ¿ÀÌ ÇÊ¿äÇÑ È¯ÀÚÀÇ ¾ç½É½Ç ¹Úµ¿¿¡ ´ëÇÑ Áß¿äÇÑ ¿ä±¸¸¦ ÃæÁ·½Ãŵ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ, ±×¸®°í °æ±âȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´

Á¦34Àå ÃÖ±ÙÀÇ ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Leadless pacemakers are a type of cardiac pacing device that delivers electrical stimulation to the heart without traditional leads (wires). These self-contained devices reduce the risk of lead-related complications such as infection, breakage, and displacement.

The primary types of leadless pacemakers include micra transcatheter pacing systems and others. The micra transcatheter pacing system (TPS) is specifically designed to provide pacing therapy for patients with bradycardia, a condition characterized by a slow or irregular heartbeat. These devices come in single-chamber and dual-chamber configurations and are utilized in various healthcare settings such as hospitals, specialty clinics, and others.

The leadless pacemakers market research report is one of a series of new reports from The Business Research Company that provides leadless pacemakers market statistics, including leadless pacemaker industry global market size, regional shares, competitors with a leadless pacemakers market share, detailed leadless pacemakers market segments, market trends, and opportunities, and any further data you may need to thrive in the leadless pacemaker industry. This leadless pacemakers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The leadless pacemakers market size has grown rapidly in recent years. It will grow from $0.58 billion in 2024 to $0.68 billion in 2025 at a compound annual growth rate (CAGR) of 15.7%. The growth in the historic period can be attributed to enhanced imaging and navigation systems, rise in focus on minimally invasive procedures, demand for improved quality of life, enhanced biocompatibility materials, and increased incidence of cardiovascular diseases.

The leadless pacemakers market size is expected to see rapid growth in the next few years. It will grow to $1.2 billion in 2029 at a compound annual growth rate (CAGR) of 15.4%. The growth in the forecast period can be attributed to expanding clinical indications, aging population, increasing focus on patient safety and outcomes, growing emphasis on sustainability, increasing public awareness and education. Major trends in the forecast period include technological advancements and innovation, integration with wearable and digital health technologies, longer battery life and durability, patient-centric design and customization, collaboration and partnerships.

The growth of the leadless pacemaker market is expected to be fueled by the increasing prevalence of heart disease in the future. Heart diseases encompass a range of conditions affecting the heart's structure or function, leading to issues such as impaired blood flow, abnormal heart rhythms, or other cardiovascular complications. The rise in heart diseases is attributed to factors such as population growth and aging, lifestyle choices, stress, physical inactivity, challenges within the healthcare system, as well as genetic and environmental factors. Leadless pacemakers offer significant benefits in managing specific heart diseases by providing effective pacing while reducing the risk of complications associated with traditional leads and offering a less invasive implantation procedure. For example, in February 2024, the World Health Organization (WHO) projected over 35 million new cases of heart disease by 2050, marking a 77% increase from the estimated 20 million cases in 2022. Thus, the increasing prevalence of heart disease is a driving force behind the growth of the leadless pacemaker market.

Leading companies in the leadless pacemaker market are focusing on developing innovative products, such as dual-chamber leadless pacemakers, to cater to a wider range of cardiac conditions and provide patients with more personalized treatment options. A dual-chamber leadless pacemaker is a cardiac pacing device designed to regulate heart rhythms by delivering electrical impulses to the right atrium and ventricle without traditional pacing leads. For instance, in February 2022, Abbott Laboratories, a US-based medical devices and healthcare company, launched the AveirTM DR, a dual-chamber pacemaker that offers synchronized, beat-by-beat pacing of the right atrium and ventricle. The Aveir DR system utilizes proprietary i2iTM communication technology to enable beat-to-beat synchronous pacing between the atrium and ventricle, delivering true Dual-chamber rate-modulated (DDDR) pacing for continuous atrioventricular (AV) synchrony. This innovative leadless pacemaker system meets the critical need for dual-chamber pacing in patients requiring pacing in both heart chambers.

In August 2022, Medtronic, an Ireland-based medical device company, completed the acquisition of Affera Inc. for $925 million. This strategic move aims to expand Medtronic's cardiac ablation offerings and venture into the cardiac mapping and navigation market, leveraging Affera's technologies to deliver innovative therapies, address the increasing demand for arrhythmia treatment, and provide a comprehensive portfolio of safe and effective solutions for cardiac arrhythmias. Affera is a US-based medical device developer specializing in heart rhythm disorder treatments.

Major companies operating in the leadless pacemakers market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, St. Jude Medical Inc., Lepu Medical Technology Co. Ltd., BIOTRONIK SE & Co. KG, LivaNova PLC, MicroPort Scientific Corporation, Oscor Inc., Sorin Group S.p.A., EBR Systems Inc., Vitatron Holding B.V., SORIN S.p.A, MEDICO S.p.A., Imricor Medical Systems Inc., Osypka Medical GmbH, Shree Pacetronix Ltd., CathRx Ltd., Cairdac

North America was the largest region in the leadless pacemakers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leadless pacemakers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the leadless pacemakers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The leadless pacemakers market consists of sales of single-chamber leadless pacemakers, nanostim leadless pacemakers, dual-chamber leadless pacemakers, wireless cardiac resynchronization therapy (CRT) systems, and MRI-compatible leadless pacemakers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Leadless Pacemakers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on leadless pacemakers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for leadless pacemakers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The leadless pacemakers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Leadless Pacemakers Market Characteristics

3. Leadless Pacemakers Market Trends And Strategies

4. Leadless Pacemakers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Leadless Pacemakers Growth Analysis And Strategic Analysis Framework

6. Leadless Pacemakers Market Segmentation

7. Leadless Pacemakers Market Regional And Country Analysis

8. Asia-Pacific Leadless Pacemakers Market

9. China Leadless Pacemakers Market

10. India Leadless Pacemakers Market

11. Japan Leadless Pacemakers Market

12. Australia Leadless Pacemakers Market

13. Indonesia Leadless Pacemakers Market

14. South Korea Leadless Pacemakers Market

15. Western Europe Leadless Pacemakers Market

16. UK Leadless Pacemakers Market

17. Germany Leadless Pacemakers Market

18. France Leadless Pacemakers Market

19. Italy Leadless Pacemakers Market

20. Spain Leadless Pacemakers Market

21. Eastern Europe Leadless Pacemakers Market

22. Russia Leadless Pacemakers Market

23. North America Leadless Pacemakers Market

24. USA Leadless Pacemakers Market

25. Canada Leadless Pacemakers Market

26. South America Leadless Pacemakers Market

27. Brazil Leadless Pacemakers Market

28. Middle East Leadless Pacemakers Market

29. Africa Leadless Pacemakers Market

30. Leadless Pacemakers Market Competitive Landscape And Company Profiles

31. Leadless Pacemakers Market Other Major And Innovative Companies

32. Global Leadless Pacemakers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Leadless Pacemakers Market

34. Recent Developments In The Leadless Pacemakers Market

35. Leadless Pacemakers Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â